Finasteride vs Pembrolizumab

Finasteride vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Finasteride and Pembrolizumab.

Mechanism of Action

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Finasteride — 5-6 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2.

Molecular Weight: Finasteride — 372.5490 g/mol.

Type: Finasteride — Small molecule; Pembrolizumab — Antibody.